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Purpose: The aim of this study was to evaluate the impact of motivational interviewing (MI)
on the quality of life and its related factors in type 2 diabetes mellitus (T2DM) patients with
poor long-term glycemic control.
Design and methods: Onehundred tenT2DMpatientswithpoor long-termglycemic control that
were hospitalized in our institution were enrolled in this study and randomly assigned to
receive eitherMI or routine diabetes education intervention. Patients' bodymass index values,
Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) scores, and levels of glycated
hemoglobin (HbA1C), triglycerides,high-and low-density lipoprotein cholesterols, Summaryof
Diabetes Self-management Activities and Diabetes Specific Quality of Life assessments were
recorded before and six months after intervention.
Results: Baseline scores for all measurements did not differ between patients in the
control and MI groups. Although MI resulted in a significant reduction of HbA1c and
serum lipid levels compared with the baseline, the effect was not significantly different
from the control intervention. However, the improvement in HOMA-IR scores was
significantly greater in the MI group compared with the control intervention (2.8 ± 2.8 vs.
5.7 ± 4.7; p ¼ 0.000). Moreover, MI significantly elevated diabetes self-management ac-
tivities ratings compared with the control intervention (13.2 ± 3.4 vs. 10.9 ± 4.3;
p ¼ 0.004).
Conclusion: Compared to routine diabetes education, MI is a more effective approach for
improving HOMA-IR and self-management of T2DM patients with poor long-term glycemic
control.
Copyright © 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved.Shi).
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Motivational interviewing (MI) is a client-centered technique
that targets the ambivalence of patients to improve their
intrinsicmotivationand correct their behavior [1,2]. It is founded
on establishing a good therapist-client partnership, which cre-
ates a friendly, supportive intervention environment that uti-
lizes individualized communication skills and methods to
respect the thoughts and feelings of the patient and promote
compliance [3,4]. It was established byMiller and Rollnick in the
early 1990s, based on the clinical treatment of patients with
alcohol dependence [4], and has become one of the major tech-
niques for behaviormodification in themanagement of chronic
diseases, such as pain control, diabetesmellitus, weight control,
and human immunodeficiency virus prevention [5,6]. Although
theefficacyofMIhasbeendocumentedbyanumberofevidence-
based medical studies [7e10], evaluation of its use China has
been minimal. Therefore, the aim of this study was to examine
the efficacy ofMI in themanagement of Chinese type 2 diabetes
mellitus (T2DM) patients with poor long-term glycemic control.2. Patients and methods
2.1. Patient selection
Patients hospitalized in the Department of Endocrinology of
The First Affiliated Hospital of Xi'an Jiaotong University be-
tween November 2010 and Mar 2011 were enrolled in the
study. The research process had got approval of the ethics
committee of the university. All the patients had provided
informed consents for research participation. The criteria for
inclusion in the study were: 1) patient age between 40 and 70
years with a diagnosis of T2DM according to the World Health
Organization diagnostic criteria [11]; 2) one- to two-year his-
tory of diabetes; 3) glycated hemoglobin (HbA1c)  9%; and 4)
an educational level of at least six years. Patients were
excluded for: 1) disturbance of consciousness, cognitive dis-
orders or defects in language communication; 2) presence of a
severe acute disease or chronic disease (e.g. severe heart
failure, lung function failure, tumors); or 3) if they were un-
willing to participate in this study. Patients were then
randomly assigned to groups receiving intervention with
either MI or routine diabetes education.
2.2. Intervention approaches
Six-month interventional approaches were separately
formulated for the two groups. During the first week of hos-
pitalization, baseline measures were collected upon admi-
nittance to the hospital, and then immediately before the first
intervention session. Diabetes education was conducted by
therapists properly trained in a diabetes education program
supported by the ChineseMedical Association. Therapists also
received training in MI techniques.
2.2.1. MI intervention
TheMI interventionprogramwas comprised of 30-minmonthly
sessions centered on the behavioral change of the patient.Before the initial interview, the time for the intervention course
was confirmed in a phone call, at which time the patient was
asked to list the problems in the intervention and to think about
it. The initial session was conducted in the education clinic,
which is quiet and comfortable. At this time, the therapist
established a mutual trust relationship with the patient and
inquired about major concerns, lifestyle, personal hobbies,
occupation, income, familymembers, etc. In thesecondsession,
treatment adherence and efficacy were evaluated and the plan
was adjusted accordingly. The patient was praised for his/her
effort and provided with further encouragement. In the third
session, the benefit of the plan was discussed. In the fourth
session, thepatient's change inbehavior over theprevious three
months was discussed and the improvement in health was
evaluated. The patient was encouraged to continue following
the plan. Over the next three months, telephone follow-ups
were performed once a month to assess the compliance and to
answer any questions raised during treatment.
The status of the patient was judged within each session as
follows: 1) In the first stage (5 min), the patient is allowed to
comment on their feelings and experiences of lifestyle, disease
control, and so on. The therapist then reports on the patient's
disease status, attitude, and difficulties encountered. 2) In the
second stage (5e15 min), the therapist verbalizes the problem
and thepatient is guided to findaway to solve theproblem from
his/her point of view. 3) In the third stage (15e25 min), the
therapist discusses the problems and solutions point-by-point
with the patient. The patient's and therapist's solutions are
both evaluated, and the patient is guided through the selection
and implementation of the agreed-upon plan. In the final stage
(25e30 min), the therapist once again invites the patient to ex-
press if he/she has any difficulties with executing the interven-
tion plan. At this time, the intervention plan is confirmed to
encourage the patient to execute the behavioral intervention.
However, the extent of the intervention should not be empha-
sized. The patient is allowed to adjust the intensity of the
compliance according to his/her practical situation, with the
support of anexpertwhocanhelphim/her to solve theproblem.
2.2.2. Control intervention
Based on the Guideline of Diabetes Education of the Diabetes
Branch of Chinese Medical Association, the routine “Five
carriage” lecture was given in four courses of 30min each. The
first lecture was given in the first week of hospitalization, and
the remaining three were given once a month following
discharge from the inpatient learning center. The course
contents included: diabetic diet and exercise therapies, blood
glucose monitoring, and diabetes medications. Following
completion of the course, monthly follow-ups were made by
phone to track the compliance and to solve problems
encountered during the six-month intervention.2.3. Evaluation methods
2.3.1. General information
The following clinical data were recorded from all patients:
name, gender, age, education experience, disease course,
body mass index (BMI), Homeostatic Model Assessment-
Insulin Resistance (HOMA-IR) score, and levels of HbA1c,
Table 1 e Baseline data.
Characteristics MI
(n ¼ 51)
Control
(n ¼ 50)
P
Age (y) 58.5 ± 5.0 59.2 ± 5.2 0.492
Diabetes mellitus disease
course (y)
1.3 ± 0.5 1.2 ± 0.4 0.270
HbA1c (%) 10.1 ± 2.7 9.7 ± 3.5 0.521
BMI (kg/m2) 25 ± 4.1 25 ± 4.4 1.000
HOMA-IR 6.2 ± 5.5 6.8 ± 4.9 0.562
TG (mmol/L) 1.5 ± 0.9 1.4 ± 0.8 0.557
HDL-C (mmol/L) 1.3 ± 0.5 1.4 ± 0.6 0.364
LDL-C (mmol/L) 3.4 ± 1.1 3.5 ± 0.9 0.619
SDSCA 8.2 ± 3.7 8.1 ± 3.7 0.891
DSQL 76.7 ± 7.1 74.8 ± 7.5 0.191
Abbreviations: BMI, body mass index; DSQL, Diabetes Specific
Quality of Life scale; HbA1c, glycated hemoglobin; HDL-C, high-
density lipoprotein cholesterol; HOMA-IR, Homeostatic Model
Assessment-Insulin Resistance; LDL-C, low-density lipoprotein
cholesterol; MI, motivational interviewing; SDSCA, Summary of
Diabetes Self-management Activities scale; TG, triglyceride.
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C) and low-density lipoprotein cholesterol (LDL-C).
2.3.2. Summary of diabetes self-management activities
(SDSCA), Chinese version [12]
The SDSCA evaluates six dimensions, including diet, exercise,
blood glucose monitoring, foot care, drugs and smoking. With
the exception of smoking, each dimension contains two
items, for a total of 11 core items overall. Each item is scored
between 0 and 7, with a total possible score of 77. An addi-
tional 14 items can be used to evaluate seven-day self-care
behavior in each dimension. The final score was calculated on
a scale of 0e10 according to standardized treatment, with a
higher score indicating good self-care behavior. The retest
reliability of the Chinese version is good, ranging from 0.763 to
1.000 for each dimension [12].
2.3.3. Diabetes Specific Quality of Life (DSQL) [13]
The DSQL evaluates 27 items in four dimensions, including
physiological function, psychological/spiritual well-being,
social relationships and treatment. Items were scored using
the Likert 5 scoring system, to yield a score between 0 and 135.
DSQL scores were normalized to standardized treatment to
give a final score between 0 and 100, with a higher score
indicating a lower quality of life. The reliability and validity of
this scale are good, with a Cronbach's a of 0.95 and a split-half
reliability of 0.91 [13,14].Table 2 e Glucose metabolism.
Baseline
MI
(n ¼ 51)
Controls
(n ¼ 50)
HbA1c (%) 10.1 ± 2.7 9.7 ± 3.5 0.
HOMA-IR 6.2 ± 5.5 6.8 ± 4.9 0.
Abbreviations: HbA1c, glycated hemoglobin; HOMA-IR, Homeostatic Mod2.4. Statistical analysis
Comparisons between MI and control groups were performed
with Student's t-tests using Stata version 10.0 statistical soft-
ware. Data are presented as mean ± standard deviation, and a
P value less than 0.05 was considered to indicate a statistically
significant difference.3. Results
3.1. Baseline patient data
A total of 110 T2DM patients were initially selected for inclu-
sion in this study. Nine of these were excluded due to cerebral
infarction, severe lung infection or dropout during follow-up,
and the remaining patients were randomly assigned to either
the MI group (n ¼ 51) or the control group (n ¼ 50). Baseline
characteristics of patients did not differ between the two
groups (Table 1).3.2. Blood glucose metabolism indicators
HbA1c levels were significantly reduced in both the MI and
control groups after the interventions (p < 0.05), with no dif-
ference between the two groups (Table 2). However, HOMA-IR
values were significantly improved in the MI group compared
with the control group after intervention (p ¼ 0.000).3.3. Serum lipids
Serum lipids did not differ between MI and control groups six
months after intervention. TG levels in the MI and control
groups after intervention were 1.42 ± 1.0 and 1.76 ± 1.3 mmol/
L, respectively. Cholesterol levels in the MI and control groups
were 1.2 ± 0.4 and 1.3 ± 0.4 mmol/L, respectively, for HDL-C,
and 2.8 ± 1.2 and 2.8 ± 1.0 mmol/L for LDL-C.3.4. Self-management and quality of life
SDSCA scoreswere significantly increased in both groups after
intervention (p < 0.05). Moreover, scores in the group receiving
MI intervention were significantly higher compared with the
control group (p ¼ 0.004) (Table 3). However, DSQL scores were
not significantly different after intervention or between
groups.After intervention
p MI
(n ¼ 51)
Controls
(n ¼ 50)
p
521 7.9 ± 1.5 8.0 ± 1.5 0.738
562 2.8 ± 2.8 5.7 ± 4.7 0.000
el Assessment-Insulin Resistance; MI, motivational interviewing.
Table 3 e Self-management and quality of life.
Baseline After intervention
MI
(n ¼ 51)
Controls
(n ¼ 50)
p MI
(n ¼ 51)
Controls
(n ¼ 50)
p
SDSCA 8.2 ± 3.7 8.1 ± 3.7 0.891 13.2 ± 3.4 10.9 ± 4.3 0.004
DSQL 76.7 ± 7.1 74.8 ± 7.5 0.191 80.0 ± 5.8 79.6 ± 5.3 0.717
Abbreviations: DSQL, Diabetes Specific Quality of Life scale; MI, motivational interviewing; SDSCA, Summary of Diabetes Self-management
Activities scale, Chinese version.
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4.1. Impact of MI on blood glucose, serum lipid
metabolism, and insulin resistance
The results of this study show thatMI wasmore effective than
routine diabetic education in improving insulin resistance in
T2DM patients with poor glycemic control. However, MI was
equally as effective for improving blood glucose levels and
serum lipid metabolism. Although a previous report by Welch
et al. indicated that MI can further improve the absolute
decrease of HbA1c by 2.1% [10], the results of our study and
others, failed to show the additional benefit. A randomized
control study comprised of 349 patients with type 1 or T2DM
failed to find an effect of MI compared with routine diabetes
education on glycemic control after one year of intervention,
though it did improve the knowledge of DM [15]. However, the
results of that study may have been influenced by the
enrollment of patients with type 1 diabetes, in which genetic
factors are known to play a greater role than patient behavior
or environment [16,17].
HOMA-IR is a more sensitive indicator of glycemic control
compared to HbA1c, which requires a longer term and larger
sample to reveal a difference. HOMA-IR is also one of the key
factors in the pathogenesis of T2DM, and improvement in
HOMA-IR can improve the status of the disease at its foun-
dation. For example, insulin sensitization can prevent the
progression of impaired fasting glucose control to T2DM
[18,19]. Further, in comparison to pharmaceutical treatment
with sulfonylureas or metformin, insulin sensitization can
maintain a much longer term of sufficient glycemic control
[20]. Therefore, MI can provide a long-term benefit for T2DM
patients.
4.2. Impact of MI on self-management
Self-management is one of the “five carriages” in diabetes
treatment, which is of substantial importance in glycemic
control and for reducing long-term complications. This study
revealed that MI intervention significantly increases SDSCA
scores, and thus the self-management of blood glucose and
disease control, consistent with findings reported by Van
Alphen [21]. Therefore, MI should be considered as an effec-
tive intervention for changing patient behavior and to
improve patient self-management. As patients with poor
glycemic control generally have problems with diabetes
recognition and inappropriate behaviors, MI may be a partic-
ularly useful approach for treating such patients.4.3. Common problems encountered with MI
intervention
The common problems encountered during the course of MI
intervention concerned diet control, exercise therapy and blood
glucose monitoring. Diet control was hindered by a lack of
understanding of, for example, how to calculate and control the
total daily caloric intake, maintaining a dietary schedule, how
to select and match recipes, the relationship between dietary
habits and diabetic control and how to dissociate these from
dietary habits of family members, or how to deal with the
hunger. Many patients had difficulty with following proper
exercise types and for a sufficient duration, accommodating
their work and lifestyles with exercise therapy, or misunder-
standing the exercise. Furthermore, as many exercised alone
and without the support of a team, the long-term adherence to
an exercise programwas not guaranteed. Finally, some patients
did not fully recognize the importance of blood glucose moni-
toring and did not establish a schedule for monitoring, had
monitoring errors because of low-quality glucometers and/or
blood glucose test strips, or had economic issues or fear of pain.4.4. Therapist qualifications for MI
In addition to having a professional knowledge of diabetes ed-
ucation, the therapist conducting theMI should possess awide-
rangeofbackgroundandpersonal knowledge.The therapistwill
encounter diverse patients from varying backgrounds; there-
fore, the topics should be individualized. In addition to educa-
tional skills, the personality and emotional intelligence of the
therapist also plays an important role. Tomaximize thebenefits
of MI, the therapist should review the patient's clinical data to
develop targeted intervention programs before the initial inter-
view. To encourage motivation for behavioral change, the
therapist should avoid “spoon-feeding” the patient with infor-
mation. MI patients should be encouraged to express their
opinion to allow the therapist to better understand the patient's
real ideas and tomake a concrete assessment, which should be
individually based and separate for each stage as the patient's
underlying philosophy gradually changes. Finally, a suitable
outpatient follow-up system is necessary to ensure that the
conceptofdiseasecontrol issuccessfullyconvertedtoapractical
andmanageable daily plan.4.5. Study limitations
The findings presented here indicate that MI can improve in-
sulin resistance and diabetes self-management, however,
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the sample sizes of the groups included in this study were
relatively small. As the short-term improvement in glycemic
control was largely due to hypoglycemic drugs, the impact of
MI and routine diabetes education may be more accurately
explained in a larger sample. Second, the study duration was
only six months. The ultimate goal of diabetes treatment is to
reduce complications and improve the quality of life. There-
fore, to accurately observe the impact of MI on these aspects, a
longer follow-up period is necessary.5. Conclusion
This study revealed that the effect of MI is similar to routine
diabetes education for improving blood glucose management
and serum lipid metabolism in T2DM patients with poor gly-
cemic control. Importantly, the results suggest that MI is su-
perior to routine education for improving insulin resistance
and diabetes self-management, which may ultimately reduce
the morbidity of long-term complications and adverse events.Conflicts of interest
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